SUBSCRIBE
SUBSCRIBE
News   Policy

German Court Overturns GlaxoSmithKline’s Patent on Advair

May 20, 2010 | 
1 min read

Reuters -- A German court ruled a key patent on GlaxoSmithKline Plc’s lung drug Advair is not valid, dealing a blow to the top-selling lung drug in Europe’s biggest market.

Legal Europe
GlaxoSmithKline
MORE ON THIS TOPIC
Contemporary art collage of a hand holding scissors. Copy space for ad. Modern design.
Layoffs
Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs
December 19, 2024
 · 
1 min read
 · 
Annalee Armstrong
machete with tip in ground outdoors
Opinion
Lessons From Humira on How to Tackle Unjust Extensions of Drug Monopolies With Policy
December 18, 2024
 · 
4 min read
 · 
Timothy Bonis
Sep 17, 2020 Fremont / CA / USA - Novo Nordisk headquarters in Silicon Valley; Novo Nordisk A/S is a Danish multinational pharmaceutical company
Manufacturing
Novo Deepens Denmark Commitment With $1.2B Rare Disease Production Facility
December 16, 2024
 · 
2 min read
 · 
Tristan Manalac
Trendy halftone collage. Concept of contracting, negotiation, contracting, favorable terms. Trendy modern retro illustration on business theme. Concept of teamwork. Vector illustration
Mergers & acquisitions
Novo Holdings Gets FTC’s Go-Ahead for Contentious $16.5B Catalent Acquisition
December 16, 2024
 · 
2 min read
 · 
Tristan Manalac